Conferences | e-learning | about important dates congress dates 27-30 june 2012 endorsements this congress is endorsed by the following societies and associations: information menu general information scientific committee faculty scientific agenda satellite symposia accreditation hotel accommodations support about the world congress webcast: mcrc management pdf announcement press information registration abstracts scientific agenda wednesday, 27 june, 2012 12:30 expert discussion (by invitation only): metastatic pancreatic cancer scientific committee and selected experts session i: selected abstracts i chairs: mario dicato, md and eric van cutsem, md, phd 15:00 welcome and introduction congress chairs mario dicato, md and eric van cutsem, md, phd 15:05 presentation of selected abstracts international experts' consensus for the definition of time to event endpoints in clinical trials (datecan project): results for pancreatic cancer f. Bonnetain, et al. , o-0001 a phase2 adjuvant trial of gi-4000 plus gemcitabine vs. cheap generic viagra free shipping Gemcitabine alone in ras + patients with resected pancreas cancer: r1 subgroup analysis d. Richards, et al. viagra canada prescription , o-0002 phase i/ii study of 90y-clivatuzumab tetraxetan (90y-hpam4) combined with gemcitabine (gem) in advanced pancreatic cancer (apc) e. Mitchell, et al. , o-0003 updated analysis of phase ii study of the anti-igf-1r antibody mk-0646 with gemcitabine +/- erlotinib for advanced pancreatic cancer (apc) r. generic viagra online overnight Shroff, et al. , o-0004 folfiri. 3 alternating with gemcitabine in patients with untreated metastatic pancreatic adenocarcinoma: the randomized multicenter ageo phase ii trial firgem i. viagra online legal Trouilloud, et al. , o-0005 session ii: cancer of the pancreas and bile ducts chairs: jordan d. Berlin, md and mario dicato, md 16:00 how to improve surgical results for pancreatic cancer? generic viagra online overnight Markus w. web pharma org buy viagra usa Bã¼echler, md 16:20 subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy manuel hidalgo, md, phd 16:40 why is pancreatic cancer so thrombogenic? Mario dicato, md 17:00 how can a borderline resectable or non-resectable pancreatic cancer become resectable? Chemo or chemoradiotherapy? Jordan d. Buy cheap online viagra Berlin, md 17:20 presentation of selected abstracts dose escalation to rash for erlotinib plus gemcitabine in patients with metastatic pancreatic cancer: the phase ii rachel (bo21128) study e. generic viagra online overnight Van cutsem, et al. , o-0006 exploratory serum biomarker analyses from bo21129, a phase ii study of erlotinib in second-line pancreatic cancer: potential role of amphiregulin m. viagra pillviagra price in pakistan Ducreux, et al. viagra online buy india , o-0007 randomized phase ii study of gemcitabine + th-302 vs gemcitabine in previously untreated patients with unresectable locally advanced and metastatic pancreatic cancer (pac) d. Ryan, et al. viagra prices in usa , o-0008 17:50 debate: this house believes that folfirinox is the best treatment for patients with metastatic pancreatic adenocarcinoma pro marc ychou, md, phd contra margaret a. Tempero, md 18:20 new agents in pancreatic cancer eileen m. O’reilly, md 18:40 should patients with resected bile duct cancer receive an adjuvant treatment? Juan w. Valle, md 19:00 adjourn closed session (by invitation only) parallel with session ii: cancer of the pancreas and bile ducts 16:00 strategy of national and international clinical trial groups 19:00 adjourn closed session thursday, 28 june 2012 closed session (by invitation only) parallel with session iii: meet the expert concurrent presentations and session iv: cancer of the liver 8:00 how to go forward with translational research in gi cancer session iii: meet the expert concurrent presentations 8:00 anal cancer robert glynne-jones, mbbs, frcr, frcp and karin haustermans, md, phd cholangiocarcinoma and gall bladder cancer juan w. Valle, md supportive cancer: management of anemia and emesis – guidelines mario dicato, md gist john r. Viagra soft Zalcberg, md, phd, fracp challenges and limitations in rectal cancer chris cunningham, md, frcsed and andre d’hoore, md, phd medical writing daniel g. Haller, md 9:00 session adjourns session iv: cancer of the liver chairs: jordi bruix, md, phd and wolff schmiegel, md, phd 9:00 presentation of selected abstract second line therapy in hepatocellular carcinoma (hcc): a randomized controlled phase 2 trial (rct) with tivantinib (arq 197) c. cheap viagra in uk Porta, et al. , o-0009 9:10 pathologic and molecular changes occurring in hcc josep m. Llovet, md 9:30 is a biopsy in a liver nodule/hcc always needed before starting a treatment? Jordi bruix, md 9:45 how to decide in the jungle of local/regional therapies for hcc? Chris verslype, md, phd 10:05 new agents on the horizon in hcc ghassan k. generic viagra online overnight Abou-alfa, md 10:20 keynote lecture 1: genetic screening for colorectal cancer: for whom and how? Judith balmaã±a, md 10:50 break and poster viewing abstracts to be presented: clinical/basic non-crc abstracts session v: rare tumors: neuroendocrine tumors and gastrointestinal stromal tumors chairs: roberto labianca, md and john r. Zalcberg, md, phd, fracp 11:20 whom to treat and how long to treat after resection of gist john r. Zalcberg, md, phd, fracp 11:35 what should a pathologist report in a net? Aurel perren, md 11:55 medical treatment of net: somatostatin anologues, biological and/or chemotherapy martyn e. buy generic viagra uk Caplin, bsc hons, dm, frcp 12:15 efficacy and toxicity of peptide receptor targeted radiopeptide therapy martin a. Walter, md 12:35 discussion 12:45 session adjourns 13:00 concurrent luncheon symposia begin 14:30 concurrent luncheon symposia adjourn session vi: esophageal cancer chairs: arnaud d. Roth, md and thomas seufferlein, md, phd 14:45 treatment of barrett’s esophagus: update on new endoscopic modalities ralf kiesslich, md, phd 15:05 is surgery alone still an option in esophageal canc. best viagra in uk

We are a creative solutions facility that specialises in interactive video, motion graphics and effects animation. Our creative teams can deliver anything from a 20 second promo for TV, to designing and implementing a large scale interactive exhibition. Email: Tel: +353 (1) 679 9328